Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A0A3Q8IJQ1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 351 | 353 | PF00675 | 0.374 |
CLV_NRD_NRD_1 | 361 | 363 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 400 | 402 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 410 | 412 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 423 | 425 | PF00675 | 0.332 |
CLV_NRD_NRD_1 | 429 | 431 | PF00675 | 0.397 |
CLV_NRD_NRD_1 | 437 | 439 | PF00675 | 0.379 |
CLV_PCSK_FUR_1 | 252 | 256 | PF00082 | 0.429 |
CLV_PCSK_FUR_1 | 280 | 284 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.553 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.468 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 351 | 353 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 361 | 363 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 400 | 402 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 409 | 411 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 423 | 425 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 429 | 431 | PF00082 | 0.397 |
CLV_PCSK_KEX2_1 | 436 | 438 | PF00082 | 0.385 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.356 |
CLV_PCSK_PC7_1 | 127 | 133 | PF00082 | 0.610 |
CLV_PCSK_PC7_1 | 250 | 256 | PF00082 | 0.560 |
CLV_PCSK_PC7_1 | 347 | 353 | PF00082 | 0.398 |
CLV_PCSK_PC7_1 | 405 | 411 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.637 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 316 | 320 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 347 | 351 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.570 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.615 |
DEG_APCC_DBOX_1 | 126 | 134 | PF00400 | 0.445 |
DEG_APCC_DBOX_1 | 23 | 31 | PF00400 | 0.521 |
DEG_APCC_DBOX_1 | 257 | 265 | PF00400 | 0.416 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.451 |
DOC_CYCLIN_RxL_1 | 280 | 291 | PF00134 | 0.530 |
DOC_MAPK_gen_1 | 280 | 290 | PF00069 | 0.403 |
DOC_MAPK_gen_1 | 3 | 9 | PF00069 | 0.406 |
DOC_MAPK_gen_1 | 320 | 330 | PF00069 | 0.401 |
DOC_MAPK_gen_1 | 451 | 461 | PF00069 | 0.499 |
DOC_MAPK_MEF2A_6 | 208 | 215 | PF00069 | 0.530 |
DOC_MAPK_MEF2A_6 | 323 | 330 | PF00069 | 0.365 |
DOC_MAPK_MEF2A_6 | 454 | 463 | PF00069 | 0.502 |
DOC_PP1_RVXF_1 | 411 | 417 | PF00149 | 0.500 |
DOC_USP7_MATH_1 | 111 | 115 | PF00917 | 0.510 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.514 |
DOC_WW_Pin1_4 | 453 | 458 | PF00397 | 0.486 |
LIG_14-3-3_CanoR_1 | 138 | 146 | PF00244 | 0.534 |
LIG_14-3-3_CanoR_1 | 323 | 329 | PF00244 | 0.367 |
LIG_14-3-3_CanoR_1 | 4 | 10 | PF00244 | 0.527 |
LIG_14-3-3_CanoR_1 | 436 | 441 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 86 | 94 | PF00244 | 0.574 |
LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.355 |
LIG_BRCT_BRCA1_1 | 41 | 45 | PF00533 | 0.527 |
LIG_CaM_IQ_9 | 354 | 370 | PF13499 | 0.337 |
LIG_deltaCOP1_diTrp_1 | 443 | 448 | PF00928 | 0.473 |
LIG_FHA_1 | 114 | 120 | PF00498 | 0.516 |
LIG_FHA_1 | 325 | 331 | PF00498 | 0.467 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.368 |
LIG_FHA_1 | 390 | 396 | PF00498 | 0.507 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.514 |
LIG_FHA_2 | 386 | 392 | PF00498 | 0.382 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.480 |
LIG_LIR_Nem_3 | 245 | 249 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 32 | 37 | PF02991 | 0.610 |
LIG_PDZ_Class_2 | 458 | 463 | PF00595 | 0.513 |
LIG_Pex14_1 | 60 | 64 | PF04695 | 0.537 |
LIG_RPA_C_Fungi | 227 | 239 | PF08784 | 0.432 |
LIG_SH2_SRC | 265 | 268 | PF00017 | 0.400 |
LIG_SH2_STAP1 | 154 | 158 | PF00017 | 0.403 |
LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.494 |
LIG_SH2_STAT3 | 154 | 157 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 384 | 387 | PF00017 | 0.380 |
LIG_SH3_3 | 439 | 445 | PF00018 | 0.466 |
LIG_SUMO_SIM_anti_2 | 102 | 108 | PF11976 | 0.495 |
LIG_UBA3_1 | 9 | 18 | PF00899 | 0.357 |
MOD_CK1_1 | 324 | 330 | PF00069 | 0.465 |
MOD_CK1_1 | 8 | 14 | PF00069 | 0.385 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.568 |
MOD_CK2_1 | 385 | 391 | PF00069 | 0.360 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.482 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.657 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.636 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.587 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.632 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.514 |
MOD_GSK3_1 | 385 | 392 | PF00069 | 0.375 |
MOD_GSK3_1 | 453 | 460 | PF00069 | 0.485 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.392 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.576 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.469 |
MOD_NEK2_1 | 321 | 326 | PF00069 | 0.398 |
MOD_NEK2_1 | 357 | 362 | PF00069 | 0.411 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.472 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.519 |
MOD_PIKK_1 | 152 | 158 | PF00454 | 0.528 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.667 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.501 |
MOD_PKA_1 | 351 | 357 | PF00069 | 0.339 |
MOD_PKA_1 | 436 | 442 | PF00069 | 0.412 |
MOD_PKA_2 | 324 | 330 | PF00069 | 0.430 |
MOD_PKA_2 | 351 | 357 | PF00069 | 0.369 |
MOD_PKA_2 | 425 | 431 | PF00069 | 0.422 |
MOD_PKA_2 | 436 | 442 | PF00069 | 0.373 |
MOD_PKA_2 | 5 | 11 | PF00069 | 0.584 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.625 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.518 |
MOD_Plk_4 | 457 | 463 | PF00069 | 0.505 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.435 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.615 |
MOD_ProDKin_1 | 453 | 459 | PF00069 | 0.491 |
MOD_SUMO_for_1 | 450 | 453 | PF00179 | 0.479 |
TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.494 |
TRG_DiLeu_BaLyEn_6 | 124 | 129 | PF01217 | 0.448 |
TRG_DiLeu_BaLyEn_6 | 33 | 38 | PF01217 | 0.381 |
TRG_ENDOCYTIC_2 | 265 | 268 | PF00928 | 0.400 |
TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.503 |
TRG_ER_diArg_1 | 137 | 140 | PF00400 | 0.462 |
TRG_ER_diArg_1 | 164 | 166 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 178 | 181 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 249 | 252 | PF00400 | 0.419 |
TRG_ER_diArg_1 | 280 | 283 | PF00400 | 0.498 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.426 |
TRG_ER_diArg_1 | 322 | 325 | PF00400 | 0.411 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 350 | 352 | PF00400 | 0.392 |
TRG_ER_diArg_1 | 399 | 401 | PF00400 | 0.378 |
TRG_ER_diArg_1 | 409 | 411 | PF00400 | 0.389 |
TRG_ER_diArg_1 | 422 | 424 | PF00400 | 0.325 |
TRG_ER_diArg_1 | 435 | 438 | PF00400 | 0.378 |
TRG_ER_diArg_1 | 84 | 87 | PF00400 | 0.562 |
TRG_Pf-PMV_PEXEL_1 | 171 | 176 | PF00026 | 0.467 |
TRG_Pf-PMV_PEXEL_1 | 35 | 39 | PF00026 | 0.601 |
TRG_Pf-PMV_PEXEL_1 | 438 | 443 | PF00026 | 0.455 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IQ74 | Bodo saltans | 26% | 72% |
A0A1X0P570 | Trypanosomatidae | 28% | 82% |
A0A422MYK4 | Trypanosoma rangeli | 27% | 78% |
A4IBR2 | Leishmania infantum | 99% | 100% |
C9ZYW1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 69% |
E9AFJ7 | Leishmania major | 91% | 100% |
V5DUN3 | Trypanosoma cruzi | 26% | 78% |